Physician profile
James Ray Fuentes
NPI 1194386144
$1,530.82
in general payments reported to CMS, 2019-2025
11 companies · $694 in 2025
The $694 reported for 2025 was more than what 78% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $117 · 2022: $296 · 2023: $248 · 2024: $175 · 2025: $694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,116.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $618.02 | 2023-2025 | Impella |
| Edwards Lifesciences Corporation | $279.06 | 2021-2025 | Mitris Resilia Mitral Valve, Carpentier-Edwards Physio II Annuloplasty Ring |
| Medtronic, INC. | $242.97 | 2021-2025 | Corevalve Evolut R |
| Ethicon US, LLC | $94.64 | 2021-2025 | Echelon Flex, Dermabond, Vistaseal |
| Baxter Healthcare | $84.83 | 2022-2023 | Tisseel |
| Boston Scientific Corporation | $71.13 | 2022-2023 | Watchman Access System |
| Molnlycke Health Care US, LLC | $38.25 | 2022-2024 | Avance, Mepilex Border Post-Op Ag |
| Stryker Corporation | $35.59 | 2024 | Photonblade, Medline Industries, INC. |
| Depuy Synthes Sales INC. | $30.19 | 2024 | Embotrap |
| Becton, Dickinson and Company | $20.36 | 2025 | Hemosphere |
| Solventum Corporation | $15.78 | 2024 | V.A.C.Ulta, V.A.C.Instill, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fuentes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.